Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Inc.（AUPH）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · AUPH · 截至 2025年9月30日
股东结构概览
254
机构持有人数
▲ 22 vs Q2
$729.82M
机构持仓总市值
▲ $232.67M vs Q2
128.60M
总流通股
freeFloat 98.16%
66.04M
13F 申报持股数
▲ 7.37M vs Q2
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
AUPH 最大股东 · 机构持仓
Q3 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
TANG CAPITAL MANAGEMENT LLC pharmaceutical preparations | 11.33M | 8.16% | 8.16% | $125.19B | Nov 14, 2025 | ▲ 1.30M |
BLACKROCK, INC. pharmaceutical preparations | 7.45M | 5.36% | 5.36% | $82.31B | Nov 12, 2025 | ▼ 244.3K |
NEA MANAGEMENT COMPANY, LLC pharmaceutical preparations | 3.97M | 2.86% | 2.86% | $43.87B | Nov 14, 2025 | — held |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP pharmaceutical preparations | 3.37M | 2.43% | 2.43% | $37.28B | Nov 13, 2025 | ▲ 2.30M |
STATE STREET CORP pharmaceutical preparations | 2.69M | 1.94% | 1.94% | $29.77B | Nov 14, 2025 | ▼ 101.3K |
MORGAN STANLEY pharmaceutical preparations | 1.95M | 1.40% | 1.40% | $21.51B | May 27, 2026 | ▼ 449.5K |
VANGUARD GROUP INC pharmaceutical preparations | 1.56M | 1.12% | 1.12% | $17.21B | Nov 7, 2025 | ▼ 163.4K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 1.49M | 1.07% | 1.07% | $16.41B | Nov 12, 2025 | ▼ 91.4K |
MARSHALL WACE, LLP pharmaceutical preparations | 1.48M | 1.07% | 1.07% | $16.39B | Nov 13, 2025 | ▲ 1.38M |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 1.45M | 1.04% | 1.04% | $16.02B | Nov 13, 2025 | ▲ 291.8K |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q3 2025 对比上季度
Q3 2025
28
增持
+11.84M 股2
新建仓
首次建仓18
减持
−2.04M 股0
清仓
完全退出净股数变化（前50家）
+9.80M
+11.84M / −2.04M
净新增持仓人
+12
新建 2 个 / 退出 0 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
AUPH 内幕交易记录
数据来源：SEC Form 4
近期内部人员净买入。 卖出可能源于预定的 10b5-1 计划，不代表负面展望。
11
买入笔数
0
卖出笔数
0.00
买卖比
$0M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
TANG KEVIN Chief Executive Officer | Jun 2, 2026 | Purchase | 206,005 | $15.28 | $3.15M | 13.04M | Form 4 ↗ |
TANG KEVIN Chief Executive Officer | Jun 1, 2026 | Purchase | 99 | $15.34 | $1.5K | 12.84M | Form 4 ↗ |
TANG KEVIN Chief Executive Officer | Jun 1, 2026 | Purchase | 343,521 | $15.28 | $5.25M | 12.84M | Form 4 ↗ |
TANG KEVIN Chief Executive Officer | May 29, 2026 | Purchase | 262,682 | $15.31 | $4.02M | 12.49M | Form 4 ↗ |
TANG KEVIN Chief Executive Officer | May 29, 2026 | Purchase | 2,299 | $15.35 | $35.3K | 12.23M | Form 4 ↗ |
TANG KEVIN Chief Executive Officer | Jun 2, 2026 | J-Other | 10,000 | $15.00 | $150.0K | 10.0K | Form 4 ↗ |
Robertson Stephen P. Chief Legal Officer | May 18, 2026 | Award | 115,541 | — | — | 621.4K | Form 4 ↗ |
Hearne Michael S Chief Financial Officer | May 18, 2026 | Award | 116,144 | — | — | 116.1K | Form 4 ↗ |
Hearne Michael S Chief Financial Officer | May 18, 2026 | Award | 70,230 | $15.28 | $1.07M | 70.2K | Form 4 ↗ |
Cole Ryan Chief Operating Officer | May 18, 2026 | Award | 116,144 | — | — | 116.1K | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
Aurinia Pharmaceuticals Inc.（AUPH）主要由机构投资者持有，机构持股比例约为 51.4%。公司内部人员持股约 1.84%，散户及公众持股约占剩余的 46.81%。
Aurinia Pharmaceuticals Inc. 最大机构股东为 TANG CAPITAL MANAGEMENT LLC，截至 September 30, 2025 持有约 11.33 million 股，占总流通股的 8.16%。
目前共有 254 家机构持有 AUPH 股票，合计持仓市值约 $729,823,224，数据来源为最新 SEC 13F 申报。
常见问题
AUPH ownershipAurinia Pharmaceuticals Inc.（AUPH）主要由机构投资者持有，机构持股约 51.4%。最大股东为 TANG CAPITAL MANAGEMENT LLC，持股比例 8.16%。内部人员持股约 1.84%。数据来源 SEC Form 13F，截至 September 30, 2025。